Cargando…

Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale

OBJECTIVE: Avoidance of colorectal cancer (CRC) screening is well documented with emotional barriers deterring screening intention and uptake. However, the assessment of such aversion is limited by the available instruments focusing on siloed emotions or screening procedures, limiting relevance to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Melanie, Oaten, Megan, Tapp, Caley, Occhipinti, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788280/
https://www.ncbi.nlm.nih.gov/pubmed/35851704
http://dx.doi.org/10.1111/ecc.13661
_version_ 1784858715943337984
author Davis, Melanie
Oaten, Megan
Tapp, Caley
Occhipinti, Stefano
author_facet Davis, Melanie
Oaten, Megan
Tapp, Caley
Occhipinti, Stefano
author_sort Davis, Melanie
collection PubMed
description OBJECTIVE: Avoidance of colorectal cancer (CRC) screening is well documented with emotional barriers deterring screening intention and uptake. However, the assessment of such aversion is limited by the available instruments focusing on siloed emotions or screening procedures, limiting relevance to the complete process of decision‐making in the CRC context. METHODS: To address this gap, psychometric properties of the newly developed Aversion to Bowel Cancer Screening Scale (ABCSS) were assessed using data from 640 CRC screening eligible asymptomatic community members. Item review and piloting reduced 179 items to the initial 29‐item scale. Using a holdout sample technique, exploratory and confirmatory factor analysis, reliability and validity checks were conducted. RESULTS: A three‐factor model (Fecal Occult Blood Test [FOBT] Aversion, Colonoscopy Aversion and Health Conscientiousness) with 21 items was identified. Analyses of the 21‐item ABCSS indicated excellent reliabilities for the scale and subscales (α = .91 to .95). Correlations with relevant existing measures, intention and behaviour indicated good construct validity. CONCLUSION: The ABCSS is a valid measure of aversion to CRC screening for asymptomatic community members facing the decision to undertake CRC screening. This instrument may provide a more comprehensive understanding of the decision‐making process for CRC screening.
format Online
Article
Text
id pubmed-9788280
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97882802022-12-28 Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale Davis, Melanie Oaten, Megan Tapp, Caley Occhipinti, Stefano Eur J Cancer Care (Engl) Original Articles OBJECTIVE: Avoidance of colorectal cancer (CRC) screening is well documented with emotional barriers deterring screening intention and uptake. However, the assessment of such aversion is limited by the available instruments focusing on siloed emotions or screening procedures, limiting relevance to the complete process of decision‐making in the CRC context. METHODS: To address this gap, psychometric properties of the newly developed Aversion to Bowel Cancer Screening Scale (ABCSS) were assessed using data from 640 CRC screening eligible asymptomatic community members. Item review and piloting reduced 179 items to the initial 29‐item scale. Using a holdout sample technique, exploratory and confirmatory factor analysis, reliability and validity checks were conducted. RESULTS: A three‐factor model (Fecal Occult Blood Test [FOBT] Aversion, Colonoscopy Aversion and Health Conscientiousness) with 21 items was identified. Analyses of the 21‐item ABCSS indicated excellent reliabilities for the scale and subscales (α = .91 to .95). Correlations with relevant existing measures, intention and behaviour indicated good construct validity. CONCLUSION: The ABCSS is a valid measure of aversion to CRC screening for asymptomatic community members facing the decision to undertake CRC screening. This instrument may provide a more comprehensive understanding of the decision‐making process for CRC screening. John Wiley and Sons Inc. 2022-07-18 2022-11 /pmc/articles/PMC9788280/ /pubmed/35851704 http://dx.doi.org/10.1111/ecc.13661 Text en © 2022 The Authors. European Journal of Cancer Care published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Davis, Melanie
Oaten, Megan
Tapp, Caley
Occhipinti, Stefano
Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale
title Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale
title_full Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale
title_fullStr Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale
title_full_unstemmed Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale
title_short Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale
title_sort development and psychometric evaluation of the aversion to bowel cancer screening scale
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788280/
https://www.ncbi.nlm.nih.gov/pubmed/35851704
http://dx.doi.org/10.1111/ecc.13661
work_keys_str_mv AT davismelanie developmentandpsychometricevaluationoftheaversiontobowelcancerscreeningscale
AT oatenmegan developmentandpsychometricevaluationoftheaversiontobowelcancerscreeningscale
AT tappcaley developmentandpsychometricevaluationoftheaversiontobowelcancerscreeningscale
AT occhipintistefano developmentandpsychometricevaluationoftheaversiontobowelcancerscreeningscale